Remission of a chiasmatic glioma in a non-NF1 patient after brief chemotherapy with vincristine and carboplatin: Case report and literature review

Journal of Neuro-Oncology

Volumn 67, Issue 1-2, 2004, Pages 95-100

  Mantadakis, Elpis ^a   Raissaki, Maria ^a   Danilatou, Vassiliki ^a   Kambourakis, Alexander ^a   Stiakaki, Eftichia ^a   Kalmanti, Maria ^a  

^a UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

Author keywords

Carboplatin; Chemotherapy; Chiasmatic glioma; Neurofibromatosis; Vincristine; Vision loss

Indexed keywords

CARBOPLATIN; CONTRAST MEDIUM; COTRIMOXAZOLE; ONDANSETRON; TEMOZOLOMIDE; VINCRISTINE;

ALOPECIA; ARTICLE; BLOOD TRANSFUSION; BONE MARROW SUPPRESSION; CANCER REGRESSION; CASE REPORT; DIAGNOSTIC IMAGING; DRUG RESPONSE; FEMALE; GLIOMA; HUMAN; MIDDLE CRANIAL FOSSA; NAUSEA; NEUROFIBROMATOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC CHIASM; SCHOOL CHILD; SIDE EFFECT; SYMPTOMATOLOGY; TRIGEMINAL NERVE; TUMOR VOLUME; URINARY TRACT INFECTION; VISION; VISUAL IMPAIRMENT;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CHILD; FEMALE; GLIOMA; HUMANS; MAGNETIC RESONANCE IMAGING; NEUROFIBROMATOSES; OPTIC CHIASM; OPTIC NERVE NEOPLASMS; VINCRISTINE;

EID: 1842484848     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:NEON.0000021740.50003.27     Document Type: Article

References (30)

1. Garvey M, Packer RJ: An integrated approach to the treatment of chiasmatic-hypothalamic gliomas. J Neuro-Oncol 28: 167-183, 1996
2. Pollack IF, Mulvihill JJ: Special issues in the management of gliomas in children with neurofibromatosis 1. J Neuro-Oncol 28: 257-268, 1996
3. Listernick R, Darling C, Greenwald M, Strauss L, Charrow J: Optic pathway tumors in children: the effect of neurofibromatosis type 1 on clinical manifestations and natural history. J Pediatr 127: 718-722, 1995
4. Habrand JL, De Crevoisier R: Radiation therapy in the management of childhood brain tumors. Childs Nerv Syst 17: 121-133, 2001
5. Constine LS, Woolf PD, Cann D, Mick G, McCormick K, Raubertas RF, Rubin P: Hypothalamic-pituitary dysfunction after radiation for brain tumors. N Engl J Med 328: 87-94, 1993
6. Dirks PB, Jay V, Becker LE, Drake JM, Humphreys RP, Hoffman HJ, Rutka JT: Development of anaplastic changes in low-grade astrocytomas of childhood. Neurosurgery 34: 68-78, 1994
7. Grill J, Couanet D, Cappelli C, Habrand JL, Rodriguez D, Sainte-Rose C, Kalifa C: Radiation-induced cerebral vasculopathy in children with neurofibromatosis and optic pathway glioma. Ann Neurol 45: 393-396, 1999
8. Neurofibromatosis: conference statement. Arch Neurol 45: 575-578, 1988
9. Gutmann DH, Aylsworth A, Carey JC, Korf B, Marks J, Pyeritz RE, Rubenstein A, Viskochil D: The diagnostic evaluation and multidisciplinary management of neurofibromatosis-1 and neurofibromatosis-2. JAMA 278: 51-57, 1997
10. Janss AJ, Grundy R, Cnaan A, Savino PJ, Packer RJ, Zackai EH, Goldwein JW, Sutton LN, Radcliffe J, Molloy PT et al.: Optic pathway and hypothalamic/chiasmatic gliomas in children younger than age 5 years with a 6-year follow-up. Cancer 75: 1051-1059, 1995
11. Listernick R, Charrow J, Greenwald M, Mets M: Natural history of optic pathway tumors in children with neurofibromatosis type 1: a longitudinal study. J Pediatr 125: 63-66, 1994
12. Alvord EC Jr, Lofton S: Gliomas of the optic nerve or chiasm. Outcome by patients' age, tumor site, and treatment. J Neurosurg 68: 85-98, 1988
13. Packer RJ, Ater J, Allen J, Phillips P, Geyer R, Nicholson HS, Jakacki R, Kurczynski E, Needle M, Finlay J, Reaman G, Boyett JM: Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas. J Neurosurg 86: 747-754, 1997
14. Packer RJ, Sutton LN, Bilaniuk LT, Radcliffe J, Rosenstock JG, Siegel KR, Bunin GR, Savino PJ, Bruce DA, Schut L: Treatment of chiasmatic/hypothalamic gliomas of childhood with chemotherapy: an update. Ann Neurol 23: 79-85, 1988
15. Petronio J, Edwards MS, Prados M, Freyberger S, Rabbitt J, Silver P, Levin VA: Management of chiasmal and hypothalamic gliomas of infancy and childhood with chemotherapy. J Neurosurg 74: 701-708, 1991
16. Pons MA, Finlay JL, Walker RW, Puccetti D, Packer RJ, McElwain M: Chemotherapy with vincristine (VCR) and etoposide (VP-16) in children with low-grade astrocytoma. J Neuro-Oncol 14: 151-158, 1992
17. Chamberlain MC, Grafe MR: Recurrent chiasmatic-hypothalamic glioma treated with oral etoposide. J Clin Oncol 13: 2072-2076, 1995
18. Moghrabi A, Friedman HS, Burger PC, Tien R, Oakes WJ: Carboplatin treatment of progressive optic pathway gliomas to delay radiotherapy. J Neurosurg 79: 223-227, 1993
19. Mahoney DH Jr, Cohen ME, Friedman HS, Kepner JL, Gemer L, Langston JW, James HE, Duffner PK, Kun LE: Carboplatin is effective therapy for young children with progressive optic pathway tumors: a Pediatric Oncology Group phase II study. J Neuro-Oncol 2: 213-220, 2000
20. Liu GT, Lessell S: Spontaneous visual improvement in chiasmatic gliomas. Am J Ophthalmol 114: 193-201, 1992
21. Perilongo G, Moras P, Carollo C, Battistella A, Clementi M, Laverda A, Murgia A: Spontaneous partial regression of low-grade glioma in children with neurofibromatosis-1: a real possibility. J Child Neurol 14: 352-356, 1999
22. Gottschalk S, Tavakolian R, Buske A, Tinschert S, Lehmann R: Spontaneous remission of chiasmatic/hypothalamic masses in neurofibromatosis type 1: report of two cases. Neuroradiology 41: 199-201, 1999
23. Brzowski A, Bazan C III, Mumma JV, Ryan SG: Spontaneous regression of optic glioma in a patient with neurofibromatosis. Neurology 42: 679-681, 1992
24. Leisti EL, Pyhtinen J, Poyhonen M: Spontaneous decrease of a pilocytic astrocytoma in neurofibromatosis type 1. AJNR Am Neuroradiol 17: 1691-1694, 1996
25. Colosimo C, Cerase A, Maira G: Regression after biopsy of a pilocytic opticochiasmatic astrocytoma in a young adult without neurofibromatosis. Neuroradiology 42: 352-356, 2000
26. Parsa CF, Hoyt CS, Lesser RL, Weinstein JM, Strother CM, Muci-Mendoza R, Ramella M, Manor RS, Fletcher WA, Repka MX, Garrity JA, Ebner RN, Monteiro ML, McFadzean RM, Rubtsova IV, Hoyt WF: Spontaneous regression of optic gliomas: thirteen cases documented by serial neuroimaging. Arch Ophthalmol 119: 516-529, 2001
27. Schmandt SM, Packer RJ, Vezina LG, Jane J: Spontaneous regression of low-grade astrocytomas in childhood. Pediatr Neurosurg 32: 132-136, 2000
28. Arnautovic KI, Husain MM, Linskey ME: Cranial nerve route entry zone primary cerebellopontine angle gliomas: a rare and poorly recognized subset of extraparenchymal tumors. J Neuro-Oncol 49: 205-212, 2000
29. Beutler AS, Hsiang JK, Moorhouse DF, Hansen LA, Alksne JF: Pilocytic astrocytoma presenting as an extracranial tumor in the cerebellopontine angle: case report. Neurosurgery 37: 125-128, 1995
30. Kuo DJ, Weiner HL, Wisoff J, Miller DC, Knopp EA, Finlay JL: Temozolomide is active in childhood, progressive, unresectable, low-grade gliomas. J Pediatr Hematol Oncol 25: 372-378, 2003